欢迎来到创赛优选商城 !
Cy3-UTP(10mM) 抑胃肽酶液 PERFEMIKER AuroraGel 标准型基质胶,不含LDEV
光引发剂LAP 人工胃液 1%柠檬酸钠缓冲液 Salkowskis比色液 人工脑脊液(aCSF,无菌)
简介:taurochenodeoxycholate是动物胆汁酸的主要生物活性物质之一。 taurochenodeoxycholate物理化学性质:
密度
1.2±0.1 g/cm3
分子式
C26H45NO6S
分子量
499.704
精确质量
499.2968
PSA
132.31
LogP
2.1
折射率
1.552
储存条件
-20°C
taurochenodeoxycholate详细介绍:
中文名称:
牛磺鹅去氧胆酸
中文别名:
牛磺鹅去氧胆酸;牛磺鹅脱氧胆酸;牛磺鹅去氧胆酸 标准品;牛磺鹅去氧胆酸对照品;牛磺鹅去氧磺酸钠;牛磺鹅脱氧胆酸(TCDCA);医药级牛磺鹅去氧胆酸
英文名称:
2-[[(4R)-4-[(3R,7R,8R,9R,10S,13R,14S,17R)-3,7-Dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid
英文别名:
Taurochenodeoxycholic acid;2-[4-(3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoylamino]ethanesulfonic acid;Chenodeoxycholyltaurine;Chenodeoxytaurocholic acid;N-(2-Sulfoethyl)-3α,7α-dihydroxy-5β-cholane-24-amide;C05465;Chenodeoxycholoyltaurine;12-Deoxycholyltaurine;2-((4R)-4-((3R,7R,8R,9S,10S,13R,14S,17R)-3,7-Dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethanesulfonic acid;2-((R)-4-((3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-Dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethanesulfonic acid;Taurochenodeoxycholic Acid-d5 (Major) (See T008133);Taurochenodesoxycholic acid;[3H]-Chenodeoxycholyltaurine;12-Desoxycholyltaurine;Chenyltaurine;Taurochenodeoxycholicacid;2-[[(4R)-4-[(3R,7R,8R,9R,10S,13R,14S,17R)-3,7-Dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,1
CAS号:
516-35-8
分子式:
分子量:
499.70
详细描述
516-35-8,taurochenodeoxycholate,上海现货。
Medlife,致力于提供高品质、高性价比小分子化合物的产品。
Medlife小分子化合物大量库存,提供超过2万种的抑制剂、激动剂、拮抗剂等产品,是药物及疾病研究的重要原料供应商。
Taurochenodeoxycholic acid是动物胆汁酸的主要生物活性物质之一。
查询关键词:“516-35-8,taurochenodeoxycholate,PC19264,上海现货”。
taurochenodeoxycholate参考文献:
[1]. Wang X, et al. Taurochenodeoxycholic acid induces NR8383 cells apoptosis via PKC/JNK-dependent pathway. Eur J Pharmacol. 2016 Sep 5;786:109-15.
[2]. Zhou C, et al. The effects of taurochenodeoxycholic acid in preventing pulmonary fibrosis in mice. Pak J Pharm Sci. 2013 Jul;26(4):761-5.
[3]. Uchida A, et al. Taurochenodeoxycholic acid ameliorates and ursodeoxycholic acid exacerbates small intestinal inflammation. Am J Physiol. 1997 May;272(5 Pt 1):G1249-57.
[4]. Liu M, et al. Effects of taurochenodeoxycholic acid on adjuvant arthritis in rats. Int Immunopharmacol. 2011 Dec;11(12):2150-8. 产品技术规格说明书由上海创赛科技有限公司收集整理,仅作参考使用。
创赛客服1
创赛客服2
创赛客服3
创赛客服4
400-608-7598